I migliori medici per il trattamento di Cancro al seno a Berlino - TOP-4 medici

F. Budach is a specialist at RadioOnkologie im Vosspalais, with leadership experience that includes serving as Clinic Director of the Charité Clinic for Radiation Oncology until 2022. He was President of DEGRO and President of the Congress, and his clinical focus includes therapy for head and neck tumors, sarcomas, and breast carcinomas. His training includes diagnostic radiology and radiation therapy at University Hospital Essen (1980-1985) and specialist certification in radiation therapy in 1985.

Maria Steingräber is a specialist at RadioOnkologie im Vosspalais in Berlin, combining Russian medical training with years of radiation oncology work in Berlin hospitals and practices. She completed specialist training at Charité (1987-1998), earned her Dr. med. in 1996 at Humboldt University Berlin, and received board certification for Radiation Oncology in 1998. Her clinical focus includes breast cancer, bronchial carcinoma, and lymphomas, and she speaks Russian, German, and English for international patients.

Volker Budach is a specialist at RadioOnkologie im Vosspalais in Berlin-Mitte, where he continues his radiation oncology work after serving as Clinic Director at the Charité Clinic for Radiation Oncology until 2022. He is a former President of DEGRO and Congress President, with a clinical focus on head and neck tumors, sarcomas, and breast carcinomas. His treatment approach includes primary radiochemotherapy with daily radiotherapy over several weeks, and radioimmunotherapy with cetuximab when standard chemotherapy options are contraindicated.

Simone Marnitz is a specialist at RadioOnkologie im Vosspalais, where she has led the private radiotherapy clinic since the end of 2022. Her background includes radiation oncology training at Charité (Berlin) and UK Essen, followed by years as a senior physician and Clinic Director at the University Hospital Cologne until 2022. She focuses on high-precision therapy for gynecological tumors, prostate cancer, and breast cancer, and serves as Congress President of the DEGRO annual congress in 2024.